CytomX Therapeutics (CTMX) PT Lowered to $3.25 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Joseph Catanzaro lowered the price target on CytomX Therapeutics (NASDAQ: CTMX) to $3.25 (from $3.50) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
